Joanna Cooper is a Neurology physician affiliated with University of California, Berkeley. OpenAlex indexes 12 publications with 1,613 citations (h-index 10); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2850 Telegraph Ave Ste 110
Berkeley, CA 94705
Telephone
510-204-8140Provider last certified this registry record 20 Jan 2021.
Clinical trials
- Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis
Sponsor: Acorda Therapeutics
- Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis
Sponsor: PDL BioPharma, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year20253 payments
- TG Therapeutics, Inc.Program year20251 payment
- Itamar Medical IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
92.1%Neuromuscular Blocker91.1%Onabotulinumtoxina100%Part B, office-administered≥11 patientsgamma-Aminobutyric Acid-ergic Agonist0.7%Baclofen100%Part D≥16 patients+ 1 more class in this area
Nervous system
6.3%Gabapentinoids1.3%Gabapentin57%Pregabalin29%Horizant14%Part D<11 patientsOther antiepileptics0.9%Levetiracetam69%Lacosamide32%Part D<11 patients+ 17 more classes in this area
Cancer & immunology
1.1%Pyrimidine Synthesis Inhibitor0.7%Teriflunomide100%Part D≥11 patientsOther immunostimulants0.2%Glatopa100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- <scp>Anti‐CD20</scp> monoclonal antibody therapy in postpartum women with neurological conditions
Annals of Clinical and Translational Neurology
2023 - A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trial
Multiple Sclerosis and Related Disorders
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Elwin Marg
University of California, Berkeley
Raphael Guzman, MD
University of California, Berkeley
Yibing Chen
University of California, Berkeley
Shirin Barez, MD
University of California, Berkeley
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”